AstraZeneca: Analysts point to promising pipeline despite Covid vaccine jitters
April 09, 2021 at 08:51 AM EDT
Controversy over AstraZeneca's Covid-19 vaccine has sparked some investor concerns about its stock, according to Jefferies – but it's not all bad news for the British pharmaceutical company.
